Reported about 9 hours ago
The U.S. government has proposed a 2.2% increase in reimbursement rates for 2026 Medicare Advantage plans offered by private insurers, reversing a previous decline and estimated to total over $21 billion when adjusted for risk scores. This favorable announcement positively impacted insurer stocks, and the final rate will be published by April 2025. Additionally, under President Biden's Inflation Reduction Act, out-of-pocket drug costs for Medicare recipients will see a small increase to $2,100 in 2026.
Source: YAHOO